Improvement in pain and function through analgesic and anti-inflammatory radiotherapy in patients with finger arthritis, medial/lateral epicondylitis or plantar fasciitis
- Conditions
- plantar fasciitis, epicondylitis, polyarthritis of the finger jointsM15.9M19.9M18M76M77.0M77.5M77.1Polyarthrosis, unspecifiedArthrosis, unspecified
- Registration Number
- DRKS00006288
- Lead Sponsor
- Kantonsspital AarauZentrum für Radio-Onkologie KSA-KSB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Age over 40 year, Karnofsky Index at least 70%, Patients cannot be pregnant, Patients of child bearing age must use a medically acceptable form of contraception during the radiotherapy as well as 12 months after, Patients cannot have any congenital disease with increased sensitivity to radiation, absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial, before patient registration/randomization, written informed consent must be given according to ICH/GCP, and national/local regulations, patients will have been treated with conventional therapeutic interventions for at least 6 months
congenital disease with increased sensitivity to radiation, psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain will be assessed using the Visual Analog Scale. Musculoskeletal function will be documented using a dynamometer for patients with hand and elbow disorders and a walking test will be performed for patients with plantar fasciitis. The HAQ (health assessment) and EQ-5D (quality of life) questionnaires will be completed by all patients. Assessments will be performed at baseline and at 2, 6 and 12 months after radiotherapy.
- Secondary Outcome Measures
Name Time Method